Drugs / GDC-0623
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01106599 | Apr 2010 → Aug 2014 | — | Genentech, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GDC-0623 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01106599 ↗ |
| Route | Oral | “administered orally” NCT01106599 ↗ |